Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Clorox (CLX)

Clorox Q4 adjusted EPS rises 58% to $2.87; FY26 outlook calls for lower sales and EPS

Mixed Impact 4 of 5 earnings Written later

Clorox reported fourth-quarter fiscal 2025 net sales up 4% to $2.0 billion and adjusted EPS up 58% to $2.87, helped by incremental ERP-related retailer shipments. For fiscal 2026 it expects net sales down 6% to 10% and adjusted EPS of $5.95 to $6.30, a decline of 18% to 23%, as the ERP shipment benefit reverses.

Key points

  • Q4 net sales rose 4% to $2.0 billion; organic sales rose 8%, with incremental ERP shipments adding about 13 to 14 points
  • Q4 diluted EPS rose 55% to $2.68 and adjusted EPS rose 58% to $2.87 versus $1.82 a year earlier
  • FY2026 diluted EPS outlook is $5.60 to $5.95, versus $6.52 in fiscal 2025; adjusted EPS outlook is $5.95 to $6.30 versus $7.72
  • Net cash provided by operations was $981 million for fiscal 2025, up 41% from $695 million

The filing

CompanyClorox (CLX)
Form8-K, current report
Filed with the SECJul 31, 2025, 4:12 PM ET
Accession number0000021076-25-000035

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 31, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.